Achieve Life Sciences (ACHV) Revenue (2010 - 2016)
Achieve Life Sciences' (ACHV) quarterly Revenue came in at $2.9 million in Q1 2016, up 113.97% YoY from $1.4 million in Q2 2015, and down 51.2% on a QoQ basis from $6.0 million in Q4 2015.
Achieve Life Sciences (ACHV) Revenue (2010 - 2016) Analysis & Trends
Achieve Life Sciences (ACHV) has 7 years of Revenue data on file, last reported at $2.9 million in Q1 2016.
- Quarterly Revenue rose 113.97% year-over-year to $2.9 million in Q1 2016, while the trailing twelve-month figure through Mar 2016 was $19.7 million (up 17.7% YoY) and the FY2015 annual result came in at $18.2 million, down 33.03% from the prior year.
- Revenue retreated to $2.9 million in Q1 2016, from $6.0 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $11.7 million in Q1 2014 to a low of $1.3 million in Q1 2012.
- A 5-year average of $5.8 million and a median of $5.7 million in 2014 frame the typical range for Revenue.
- Annual changes were most pronounced in 2012 — Revenue surged 691.26% — and 2015, when it tumbled 88.29%.
- Tracing ACHV's Revenue over 5 years: stood at $9.8 million in 2012, then declined by 12.02% to $8.6 million in 2013, then tumbled by 34.3% to $5.7 million in 2014, then rose by 6.56% to $6.0 million in 2015, then tumbled by 51.2% to $2.9 million in 2016.
- The last three Revenue figures came in at $2.9 million (Q1 2016), $6.0 million (Q4 2015), and $6.7 million (Q3 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Achieve Life Sciences | 330.88 Mn | 330.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 2.94 Mn |
| Dec 31, 2015 | 6.02 Mn |
| Sep 30, 2015 | 6.74 Mn |
| Jun 30, 2015 | 4.03 Mn |
| Mar 31, 2015 | 1.37 Mn |
| Dec 31, 2014 | 5.65 Mn |
| Sep 30, 2014 | 4.80 Mn |
| Jun 30, 2014 | 4.93 Mn |
| Mar 31, 2014 | 11.73 Mn |
| Dec 31, 2013 | 8.60 Mn |
| Sep 30, 2013 | 9.86 Mn |
| Jun 30, 2013 | 6.34 Mn |
| Mar 31, 2013 | 5.08 Mn |
| Dec 31, 2012 | 9.78 Mn |
| Sep 30, 2012 | 6.57 Mn |
| Jun 30, 2012 | 2.43 Mn |
| Mar 31, 2012 | 1.32 Mn |
| Dec 31, 2011 | 1.24 Mn |
| Sep 30, 2011 | 1.17 Mn |
| Jun 30, 2011 | 1.89 Mn |